Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse
Roman M. Shapiro, Grace Birch, Guangan Hu, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 11
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Natural killer cells in antitumour adoptive cell immunotherapy
Tamara Laskowski, Alexander Biederstädt, Katayoun Rezvani
Nature reviews. Cancer (2022) Vol. 22, Iss. 10, pp. 557-575
Open Access | Times Cited: 467
Natural killer cell therapies
Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 727-736
Closed Access | Times Cited: 134
Allogeneic natural killer cell therapy
Melissa M. Berrien-Elliott, Miriam T. Jacobs, Todd A. Fehniger
Blood (2022) Vol. 141, Iss. 8, pp. 856-868
Open Access | Times Cited: 109
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 44
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 28
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer
Roman M. Shapiro, Michal Sheffer, Matthew A. Booker, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Antonio Valeri, Almudena García-Ortiz, Eva Castellano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
Iñigo Terrén, Ane Orrantia, Gabirel Astarloa-Pando, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
Tatjana Sauerer, Giuliano Filippini Velázquez, Christoph Schmid
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 34
Chimeric antigen receptor engineered natural killer cells for cancer therapy
Yalan Zhang, Weilin Zhou, Jianping Yang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 26
Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy
Andreia Maia, Mubin Tarannum, Joana R. Lérias, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 451-451
Open Access | Times Cited: 11
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy
Katie Maurer, Joseph H. Antin
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
Johannes Schetelig, Henning Baldauf, Falk Heidenreich, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Cytokines drive the formation of memory-like NK cell subsets via epigenetic rewiring and transcriptional regulation
Jennifer A. Foltz, Jennifer Tran, Pamela Wong, et al.
Science Immunology (2024) Vol. 9, Iss. 96
Closed Access | Times Cited: 8
iPSC-derived CD19 CAR NK cells for relapsed or refractory lymphoma
Roman M. Shapiro, Rizwan Romee
The Lancet (2025) Vol. 405, Iss. 10473, pp. 98-99
Closed Access | Times Cited: 1
Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancer
Ye Li, Katayoun Rezvani, Hind Rafei
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 217-235
Open Access | Times Cited: 21
Umbilical cord blood derived cellular therapy: advances in clinical development
Jiasheng Wang, Leland Metheny
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
NK cell defects: implication in acute myeloid leukemia
Selma Z. D’Silva, Meenakshi Singh, Andrea S. Pinto
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Targeting NKG2D/NKG2DL axis in multiple myeloma therapy
Zhaoyun Liu, Hao Wang, Hui Liu, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 1-11
Open Access | Times Cited: 6
CAR memory–like NK cells targeting the membrane proximal domain of mesothelin demonstrate promising activity in ovarian cancer
Mubin Tarannum, Khanhlinh Dinh, Juliana Vergara, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 6
Therapeutic effect of small extracellular vesicles from cytokine-induced memory-like natural killer cells on solid tumors
Ying‐Hong Shi, Yanxia Chen, Yi Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
The application of autologous cancer immunotherapies in the age of memory-NK cells
Gaby D. Lizana‐Vasquez, Madeline Torres‐Lugo, R. Brent Dixon, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
Miriam T. Jacobs, Pamela Wong, Alice Y. Zhou, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 20, pp. 4196-4208
Closed Access | Times Cited: 13
The role and novel use of natural killer cells in graft-versus-leukemia reactions after allogeneic transplantation
Ashley Hadjis, Shannon R. McCurdy
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top